A Study of JNJ-68179280 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

March 7, 2023

Study Completion Date

March 13, 2023

Conditions

Healthy

Interventions

DRUG

JNJ-68179280

JNJ-68179280 will be administered as an oral capsule.

OTHER

Placebo

Matching placebo will be administered as an oral capsule.

Trial Locations (1)

Celerion, Lincoln

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY